Discussing axSpA: Real-world outcomes for patients with axSpA receiving SC infliximab
The IMID Forum
- Published
- December 11, 2025
- Duration
- 13:08
- Summary source
- description
- Last updated
- Jun 21, 2026
Discusses Join Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the wo…
Summary
Join Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the world of axSpA. This month, the conversation covered a retrospective, multinational, cross-sectional survey of real-world outcomes for patients with axial spondyloarthritis receiving subcutaneous infliximab
Intelligent report
Sign in to read teasers, or upgrade to Research Pro to commission a new dossier for this episode. Learn more →
Show notes
Join Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the world of axSpA. This month, the conversation covered a retrospective, multinational, cross-sectional survey of real-world outcomes for patients with axial spondyloarthritis receiving subcutaneous infliximab